Building on our previous study showing that EZH2 binds to p38α MAPK in ER- breast cancer cells and leads to p38 MAPK signaling activation15, here we document direct and strong nanomolar binding affinity of EZH2 to p38α using Biolayer Interferometry. The gene discussed is EZH2; the disease is breast cancer.